United Therapeutics reported $201.8M in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Amarin AMRN:US -37619000 9.31M
Baxter International BAX:US $ 432M 99M
Bayer BAYN:GR 4.17B 704M
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Biogen BIIB:US $ 940.9M 409.4M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 1.82B 600M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Insmed INSM:US $ -100938000 513K
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Intra Cellular Therapies ITCI:US $ -72662000 13.34M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Johnson & Johnson JNJ:US $ 6941M 599M
Lexicon Pharmaceuticals LXRX:US -24007000 627K
Moderna Inc MRNA:US 2.45B 1.78B
Omeros OMER:US $ -35046000 65.69M
Pfizer PFE:US $ 12099M 2104M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Seattle Genetics SGEN:US $ -133111000 61K
Teva Pharmaceutical TEVA:IT 734M 55M
United Therapeutics UTHR:US $ 201.8M 86.2M
Vertex Pharmaceuticals VRTX:US $ 1134.8M 101.4M